AAAAAA

   
Results: 1-10 |
Results: 10
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection
Authors: Kim, JH Mascola, JR Ratto-Kim, S VanCott, TC Loomis-Price, L Cox, JH Michael, NL Jagodzinski, L Hawkes, C Mayers, D Gilliam, BL Birx, DC Robb, ML
Citation: Jh. Kim et al., Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection, AIDS RES H, 17(11), 2001, pp. 1021-1034
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120
Authors: Hioe, CE Tuen, M Chien, PC Jones, G Ratto-Kim, S Norris, PJ Moretto, WJ Nixon, DF Gorny, MK Zolla-Pazner, S
Citation: Ce. Hioe et al., Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120, J VIROLOGY, 75(22), 2001, pp. 10950-10957
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4(+) T cell-proliferative responses to glycoprotein 120
Authors: Hioe, CE Jones, GJ Rees, AD Ratto-Kim, S Birx, D Munz, C Gorny, MK Tuen, M Zolla-Pazner, S
Citation: Ce. Hioe et al., Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4(+) T cell-proliferative responses to glycoprotein 120, AIDS RES H, 16(9), 2000, pp. 893-905
A phase I/II trial of HIVSF2 gp120/MF59 vaccine in seronegative Thais
Authors: Nitayaphan, S Khamboonruang, C Sirisophana, N Morgan, P Chiu, J Duliege, AM Chuenchitra, C Supapongse, T Rungruengthanakit, K deSouza, M Mascola, JR Boggio, K Ratto-Kim, S Markowitz, LE Birx, D Suriyanon, V McNeil, JG Brown, AE Michael, RA
Citation: S. Nitayaphan et al., A phase I/II trial of HIVSF2 gp120/MF59 vaccine in seronegative Thais, VACCINE, 18(15), 2000, pp. 1448-1455
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers
Authors: Birx, DL Loomis-Price, LD Aronson, N Brundage, J Davis, C Deyton, L Garner, R Gordin, F Henry, D Holloway, W Kerkering, T Luskin-Hawk, R McNeil, J Michael, N Pierce, PF Poretz, D Ratto-Kim, S Renzullo, P Ruiz, N Sitz, K Smith, G Tacket, C Thompson, M Tramont, E Yangco, B Yarrish, R Redfield, RR
Citation: Dl. Birx et al., Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers, J INFEC DIS, 181(3), 2000, pp. 881-889
Varicella immunity: persistent serologic non-response to immunization
Authors: Katial, RK Ratto-Kim, S Sitz, KV Moriarity, R Engler, RJM
Citation: Rk. Katial et al., Varicella immunity: persistent serologic non-response to immunization, ANN ALLER A, 82(5), 1999, pp. 431-434
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
Authors: Sei, S Sandelli, SL Theofan, G Ratto-Kim, S Kumagai, M Loomis-Price, LD Cox, JH Jarosinski, P Walsek, CM Brouwers, P Venzon, DJ Xu, J Pizzo, PA Moss, RB Robb, ML Wood, LV
Citation: S. Sei et al., Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection, J INFEC DIS, 180(3), 1999, pp. 626-640
Proliferative responses to human immunodeficiency virus type 1 (HTV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls
Authors: Sitz, KV Ratto-Kim, S Hodgkins, AS Robb, ML Birx, DL
Citation: Kv. Sitz et al., Proliferative responses to human immunodeficiency virus type 1 (HTV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls, J INFEC DIS, 179(4), 1999, pp. 817-824
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response
Authors: Ratto-Kim, S Sitz, KV Garner, RP Kim, JH Davis, C Aronson, N Ruiz, N Tencer, K Redfield, RR Birx, DL
Citation: S. Ratto-kim et al., Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response, J INFEC DIS, 179(2), 1999, pp. 337-344
Generation and expansion of HIV-1 CD4+ antigen-specific T cell lines
Authors: Ratto-Kim, S
Citation: S. Ratto-kim, Generation and expansion of HIV-1 CD4+ antigen-specific T cell lines, METH MOL M, 17, 1999, pp. 391-395
Risultati: 1-10 |